Is the Options Market Predicting a Spike in Cross Country Healthcare (CCRN) Stock?
Cross Country Survey Reveals Digital Workforce Solutions as Key to Overcoming Healthcare Staffing Crisis
Cross Country Healthcare Shares Hit 52-Week Low After Removal From S&P SmallCap 600
Ensign Set to Join S&P MidCap 400; Curbline Properties, TransMedics to Join S&P SmallCap 600
Curbline Properties To Be Added To S&P SmallCap 600 Effective Prior To Open Of Trading On October 1, Replacing Cross Country Healthcare
Barrington Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19
Barrington analyst Kevin Steinke maintains $Cross Country Healthcare(CCRN.US)$ with a buy rating, and maintains the target price at $19.According to TipRanks data, the analyst has a success rate of 60
Declining Stock and Decent Financials: Is The Market Wrong About Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
Should You Consider Selling Cross Country Healthcare (CCRN)?
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Shares Could Be 38% Below Their Intrinsic Value Estimate
Cross Country Named Most Loved Workplace for 2024
Cross Country Healthcare Issues Non-Binding Press Release
Cross Country Healthcare to Attend the Morgan Stanley 22nd Annual Global Healthcare Conference and the 17th Annual Barrington Research Virtual Fall Investment Conference
There May Be Reason For Hope In Cross Country Healthcare's (NASDAQ:CCRN) Disappointing Earnings
Barrington Research Maintains Outperform on Cross Country Healthcare, Lowers Price Target to $19
Buy Rating Affirmed for Cross Country Healthcare Amidst Resilient Q2 Performance and Strategic Growth Potential
Results: Cross Country Healthcare, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Cross Country Healthcare Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Cross Country Healthcare | 10-Q: Q2 2024 Earnings Report
There's No Escaping Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Muted Earnings Despite A 34% Share Price Rise
Truist Adjusts Cross Country Healthcare's PT to $17 From $16, Keeps Hold Rating